3rd Annual Pharma/Life Science Virtual Summit

Jul 11 2023, 3:00pm

3Sessions
Share on:

Jul 11 2023, 3:00pm

3talks
Share on:

Join us for our 3rd Annual Pharma/Life Science Virtual Summit as our carefully curated experts dive into everything from exploring unconventional methods for mental health treatment to discovering the full potential of biosimilars and biologics. This summit will also cover how to achieve supply chain sustainability in the pharmaceutical industry, closing the equity gap around digital health solutions and maximizing minimally invasive surgeries to create better patient outcomes.

Agenda

Available on demand

Jul 11 2023, 60 mins

Unveiling Cannabis: Exploring Therapeutic Benefits and Regulatory Implications

Peter Grinspoon, M.D, Primary Care Doctor and Cannabis Specialist at Harvard Medical

In the healthcare industry, cannabis holds promising therapeutic benefits for various health conditions; however, regulatory implications and evidence-based regulations must be carefully considered and developed to ensure safe and responsible use. In this keynote presentation, Peter Grinspoon, MD, primary care physician, educator, and cannabis specialist at Massachusetts General Hospital; an instructor at Harvard Medical School; and a certified health and wellness coach, reveals the truth about cannabis and sheds light on its potential benefits and risks. He will also discuss the therapeutic potential of cannabis, responsible usage, and the impact of cannabis legalization on the healthcare system and patient care.

Learning Objectives
• Discover the therapeutic potential of cannabis for chronic health conditions and gain an understanding of the importance of responsible use
• Explore the risks and challenges associated with cannabis use, with a particular focus on addiction and recovery
• Engage in a discussion about the impact of cannabis legalization on healthcare and patient care, emphasizing the need for evidence-based regulations and further research in the field
Jul 11 2023, 45 mins

The Future of Specialty Pharmacy

Gina Lohr, Director of Research, Advisory Board

Join this webinar to learn about the current trends shaping the specialty pharmacy market, and how these pharmacies will change in the coming 5-10 years. This session will focus on the shifting landscape of specialty medications, the evolving demands on specialty pharmacies, and opportunities for collaboration between stakeholders such as specialty pharmacies, pharmaceutical manufacturers, health plans, and PBMs.

Things you’ll learn:
• How stakeholders will need to partner and collaborate to meet new challenges
• Where the specialty pharmacy market currently stands, and our predictions on where it’s headed
• Which disruptors are worth watching in the specialty pharmacy market
Jul 11 2023, 60 mins

Navigating Supply Chain Dynamics & Pricing Disparities of Biologics, Biosimilars

L. Ross Day, R.Ph. and Antonio Ciaccia

The accessibility and affordability of biologics and biosimilars are greatly influenced by the dynamics and pricing differences within the prescription drug supply chain. These factors can impede the adoption of biosimilars, leading to reduced competition and fewer cost savings for patients and healthcare systems. Ross Day, RPH, DP, former Director of Pharmacy at Vizient and current pharmaceutical consultant, and Antonio Ciaccia, CEO and co-founder of 46brooklyn, President of 3 Axis Advisors, will explore the dynamics of the prescription drug supply chain and pricing disparities related explicitly to biologics and biosimilars during this panel discussion.

Learning Objectives
• Gain comprehensive insight into the profound impact of prescription drug chain dynamics and pricing disparities on the accessibility and affordability of biologics and biosimilars
• Explore the intricacies surrounding barriers to biosimilar adoption and their far-reaching effects on market competition
• Engage in meaningful discussions to devise effective strategies for mitigating pricing disparities, enhancing access to biologics and biosimilars, and realizing substantial cost savings for patients and healthcare systems

Presenters

Peter Grinspoon, MD

Primary Care Doctor and Cannabis Specialist

Harvard Medical
Gina Lohr

Director of Research

Advisory Board
Antonio Ciaccia

President

3 Axis Advisors
L. Ross Day, R.Ph.

Independent Pharmacy Industry Consultant, Retired Director of Pharmacy Contracting

Vizient, LLC